With a new targeting strategy, researchers can now change where and when therapeutic T cells are activated, making cytokine therapy more useful in clinical settings. Researchers from the National ...

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects. Cytokines are molecular messengers released by ...

CAR-T cell therapy offers the hope of a cure to a number of cancer patients. Yet, in spite of the great effectiveness, more attention has been paid to the toxicity of the therapy known as cytokine ...

Signaling proteins called cytokines can trigger a powerful anti-cancer response, but the challenge of cytokine therapy is keeping that effect from going beyond the tumor. Avenge Bio’s technology can ...

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...

The global GMP cytokine market is expected to grow with a CAGR of 8.4% from 2025 to 2031. The major drivers for this market are the increasing demand for immunotherapies, the risi ...

It’s been a busy five months since cytokine therapy startup Mural Oncology landed its first big check after spinning out of Alkermes. Besides the usual new-business housekeeping, the company is in the ...

Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm of cancer treatment has shifted as a result of these developments. Activating innate ...

Researchers have developed a new method of locally delivering cytokines alongside T cells that could lead to improved CAR-T cell therapies. CAR-T cell therapies utilize engineered T cells that have a ...

Cancer immunotherapy is an evolving field of research. Cytokines are a key area of interest in cancer immunotherapy; however, challenges are faced when translating their use from the lab to the clinic ...